Skip to main content

WPI 3155 (Modafinil 200 mg)

Pill with imprint WPI 3155 is White, Capsule-shape and has been identified as Modafinil 200 mg. It is supplied by Watson Laboratories, Inc.

Modafinil is used in the treatment of narcolepsy; obstructive sleep apnea/hypopnea syndrome; shift work sleep disorder and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Modafinil 200 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 3155

Modafinil

Imprint
WPI 3155
Strength
200 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Watson Laboratories, Inc.
Inactive Ingredients
lactose monohydrate, corn starch, crospovidone, croscarmellose sodium, silicon dioxide, magnesium stearate, magnesium silicate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-3500 (Discontinued) Watson Pharmaceuticals, Inc.
42291-0600 (Discontinued) AvKare, Inc.
00904-6424 (Discontinued) Major Pharmaceuticals

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.